{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:45:46Z","timestamp":1793195146387,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.psychres.2022.114762","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T02:08:54Z","timestamp":1659492534000},"page":"114762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study"],"prefix":"10.1016","volume":"316","author":[{"given":"Hualin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuirong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.psychres.2022.114762_bib0001","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1139\/cjpp-2013-0185","article-title":"Atypical antipsychotics such as risperidone, but not paliperidone, worsen vascular endothelial function via upregulation of adhesion molecules VCAM-1, ICAM-1, and E-selectin in diabetic rats","volume":"91","author":"Aboul-Fotouh","year":"2013","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"9","key":"10.1016\/j.psychres.2022.114762_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106342","article-title":"Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia","volume":"9","author":"Aleksovska","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.psychres.2022.114762_bib0003","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","article-title":"Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies","volume":"139","author":"Alvarez-Jimenez","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2022.114762_bib0004","unstructured":"American Psychiatric Association, 2009. Diagnostic and statistical manual of mental disorders."},{"key":"10.1016\/j.psychres.2022.114762_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2202-15-56","article-title":"Oxidative-stress induced increase in circulating fatty acids does not contribute to phospholipase A2-dependent appetitive long-term memory failure in the pond snail Lymnaea stagnalis","volume":"15","author":"Beaulieu","year":"2014","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/pteridines-2020-0012","article-title":"Plasma soluble P-selectin correlates with triglycerides and nitrite in overweight\/obese patients with schizophrenia","volume":"31","author":"Bourassa","year":"2020","journal-title":"Pteridines"},{"issue":"4 Suppl","key":"10.1016\/j.psychres.2022.114762_bib0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1359786810385491","article-title":"A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality","volume":"24","author":"Bradley","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2022.114762_bib0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15622970310029916","article-title":"Creatine kinase BB in brain in schizophrenia","volume":"4","author":"Burbaeva","year":"2003","journal-title":"World J. Biol. Psychiatry"},{"issue":"22","key":"10.1016\/j.psychres.2022.114762_bib0009","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1007\/s00216-019-01956-2","article-title":"Quantitative monitoring of a panel of stress-induced biomarkers in human plasma by liquid chromatography-tandem mass spectrometry: an application in a comparative study between depressive patients and healthy subjects","volume":"411","author":"Cai","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.psychres.2022.114762_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fpsyt.2018.00073","article-title":"Neurosteroids in schizophrenia: pathogenic and therapeutic implications","volume":"9","author":"Cai","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114762_bib0011","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.02.004","article-title":"Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-na\u00efve patients with schizophrenia","volume":"90","author":"Cai","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.psychres.2022.114762_bib0012","doi-asserted-by":"crossref","first-page":"e1130","DOI":"10.1038\/tp.2017.94","article-title":"Therapeutic efficacy of atypical antipsychotic drugs by targeting multiple stress-related metabolic pathways","volume":"7","author":"Cai","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2022.114762_bib0013","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1021\/pr300459d","article-title":"Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-na\u00efve schizophrenia patients after treatment with risperidone","volume":"11","author":"Cai","year":"2012","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00213-005-0279-x","article-title":"The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects","volume":"185","author":"Cohrs","year":"2006","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0015","doi-asserted-by":"crossref","first-page":"e00915","DOI":"10.1002\/prp2.915","article-title":"Impact of schizophrenia relapse definition on the comparative effectiveness of oral versus injectable antipsychotics: a systematic review and meta-analysis of observational studies","volume":"10","author":"Cristarella","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJMoa002028","article-title":"A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia","volume":"346","author":"Csernansky","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.psychres.2022.114762_bib0017","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1017\/S0033291715001282","article-title":"Pituitary gland volume and psychosocial stress among children at elevated risk for schizophrenia","volume":"45","author":"Cullen","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2022.114762_bib0018","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1192\/bjp.146.5.474","article-title":"Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine\/placebo trial. III. Relapse postponement or relapse prevention? The implications for long-term outcome","volume":"146","author":"Curson","year":"1985","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114762_bib0019","first-page":"R698","article-title":"Increase of total creatine in human brain after oral supplementation of creatine-monohydrate","volume":"277","author":"Dechent","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11126-017-9514-y","article-title":"Elevated plasma S100B, psychotic symptoms, and cognition in schizophrenia","volume":"89","author":"Deng","year":"2018","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.psychres.2022.114762_bib0021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-244X-13-50","article-title":"The nature of relapse in schizophrenia","volume":"13","author":"Emsley","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2022.114762_bib0022","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/schbul\/sby125","article-title":"Oxidative stress and inflammation in first-episode psychosis: a systematic review and meta-analysis","volume":"45","author":"Fraguas","year":"2019","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.psychres.2022.114762_bib0023","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.psychres.2015.08.018","article-title":"Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia","volume":"229","author":"Gadelha","year":"2015","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.psychres.2022.114762_bib0024","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/acps.12854","article-title":"Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia","volume":"137","author":"Galling","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.psychres.2022.114762_bib0025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.psychres.2022.114762_bib0026","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0952-3278(96)90154-4","article-title":"Phospholipase A2 and the hypofrontality hypothesis of schizophrenia","volume":"55","author":"Gattaz","year":"1996","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"7","key":"10.1016\/j.psychres.2022.114762_bib0027","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.euroneuro.2009.04.003","article-title":"Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice","volume":"19","author":"Goodwin","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0028","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000510696","article-title":"Allostatic load and its impact on health: a systematic review","volume":"90","author":"Guidi","year":"2021","journal-title":"Psychother. Psychosom."},{"issue":"12","key":"10.1016\/j.psychres.2022.114762_bib0029","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/jamapsychiatry.2017.3191","article-title":"Inflammatory biomarkers and risk of schizophrenia: a 2-sample mendelian randomization study","volume":"74","author":"Hartwig","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2022.114762_bib0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10253890.2016.1193146","article-title":"Cognitive impairment and cortisol levels in first-episode schizophrenia patients","volume":"19","author":"Havelka","year":"2016","journal-title":"Stress"},{"key":"10.1016\/j.psychres.2022.114762_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113305","article-title":"Uric acid levels in subjects with schizophrenia: a systematic review and meta-analysis","volume":"292","author":"He","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2022.114762_bib0032","doi-asserted-by":"crossref","first-page":"27584","DOI":"10.1038\/srep27584","article-title":"Higher plasma S100B concentrations in schizophrenia patients, and dependently associated with inflammatory markers","volume":"6","author":"Hong","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.psychres.2022.114762_bib0033","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114762_bib0034","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567202612666150603140912","article-title":"Acute and chronic treatments with quetiapine increase mitochondrial respiratory chain complex activity in the rat brain","volume":"12","author":"Ign\u00e1cio","year":"2015","journal-title":"Curr. Neurovasc. Res."},{"issue":"2","key":"10.1016\/j.psychres.2022.114762_bib0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.psychres.2022.114762_bib0036","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0010-440X(91)90085-Q","article-title":"SCID-PANSS: two-tier diagnostic system for psychotic disorders","volume":"32","author":"Kay","year":"1991","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114762_bib0037","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.schres.2019.07.057","article-title":"Validation of oxidative stress assay for schizophrenia","volume":"212","author":"Kim","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2022.114762_bib0038","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpsychires.2021.04.019","article-title":"Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia","volume":"138","author":"Koz\u0142owska","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0039","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br. Med. Bull."},{"issue":"22","key":"10.1016\/j.psychres.2022.114762_bib0040","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1007\/s00213-014-3764-2","article-title":"Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice","volume":"231","author":"Laoutidis","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"issue":"10","key":"10.1016\/j.psychres.2022.114762_bib0041","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2017.16121358","article-title":"Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, bayesian meta-analysis, and meta-regression of efficacy predictors","volume":"174","author":"Leucht","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2022.114762_bib0042","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"9831","key":"10.1016\/j.psychres.2022.114762_bib0043","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.psychres.2022.114762_bib0044","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/0893-133X(95)00200-W","article-title":"Psychobiologic correlates of treatment response in schizophrenia","volume":"14","author":"Lieberman","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2022.114762_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0925-4927(03)00046-5","article-title":"Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate","volume":"123","author":"Lyoo","year":"2003","journal-title":"Psychiatry Res."},{"issue":"11","key":"10.1016\/j.psychres.2022.114762_bib0046","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2009.06.005","article-title":"Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study","volume":"66","author":"Meyer","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114762_bib0047","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2018.06.023","article-title":"Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia","volume":"202","author":"Mohite","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2022.114762_bib0048","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.schres.2019.08.035","article-title":"Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: a systematic review","volume":"225","author":"Moncrieff","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2022.114762_bib0049","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2012.10.022","article-title":"The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia","volume":"48","author":"Na","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2022.114762_bib0050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ijnp\/pyaa050","article-title":"A study in first-episode psychosis patients: does angiotensin I-converting enzyme (ACE) activity associated with genotype predict symptoms severity reductions after treatment with the atypical antipsychotic risperidone?","volume":"23","author":"Nani","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2022.114762_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.703783","article-title":"Inosine as a tool to understand and treat central nervous system disorders: a neglected actor?","volume":"15","author":"Nascimento","year":"2021","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.psychres.2022.114762_bib0052","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40263-019-00632-4","article-title":"The possible role of the angiotensin system in the pathophysiology of schizophrenia: implications for pharmacotherapy","volume":"33","author":"Oh","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2022.114762_bib0053","first-page":"32","article-title":"Definitions and drivers of relapse in patients with schizophrenia: a systematic literature","volume":"12","author":"Olivares Jos\u00e9","year":"2013","journal-title":"review"},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0054","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pscychresns.2008.06.002","article-title":"Creatine abnormalities in schizophrenia and bipolar disorder","volume":"172","author":"Ong\u00fcr","year":"2009","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.psychres.2022.114762_bib0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/138161211795049589","article-title":"Steroid 5\u03b1-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders","volume":"17","author":"Paba","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"9","key":"10.1016\/j.psychres.2022.114762_bib0056","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40273-017-0515-3","article-title":"The cost of relapse in schizophrenia","volume":"35","author":"Pennington","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.psychres.2022.114762_bib0057","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/glia.23245","article-title":"Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy","volume":"66","author":"Plemel","year":"2018","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-019-0090-z","article-title":"The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research","volume":"6","author":"Potkin","year":"2020","journal-title":"npj Schizophr."},{"issue":"7","key":"10.1016\/j.psychres.2022.114762_bib0059","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114762_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2017.01.056","article-title":"Postmortem studies on mitochondria in schizophrenia","volume":"187","author":"Roberts","year":"2017","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.psychres.2022.114762_bib0061","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/YCO.0000000000000529","article-title":"Smoking in schizophrenia: recent findings about an old problem","volume":"32","author":"Sagud","year":"2019","journal-title":"Curr. Opin. Psychiatry"},{"issue":"21","key":"10.1016\/j.psychres.2022.114762_bib0062","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2174\/156802612805289845","article-title":"Alterations of brain membranes in schizophrenia: impact of phospholipase A(2)","volume":"12","author":"Schaeffer","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"issue":"8\u20139","key":"10.1016\/j.psychres.2022.114762_bib0063","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s007020170026","article-title":"Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia","volume":"108","author":"Schmitt","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psychres.2022.114762_bib0064","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fphar.2012.00195","article-title":"Glutamate neurocircuitry: theoretical underpinnings in schizophrenia","volume":"3","author":"Schwartz","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2022.114762_bib0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbi.2020.08.033","article-title":"Interleukin-6 in schizophrenia: cause of death matters","volume":"90","author":"Scorza","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.psychres.2022.114762_bib0066","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00134-013-2935-7","article-title":"Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study","volume":"39","author":"Seymour","year":"2013","journal-title":"Intensiv. Care Med."},{"issue":"5","key":"10.1016\/j.psychres.2022.114762_bib0067","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.1780080429","article-title":"Role of the intestinal tract in the elimination of uric acid","volume":"8","author":"Sorensen","year":"1965","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.psychres.2022.114762_bib0068","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.psyneuen.2016.08.019","article-title":"Progesterone: the neglected hormone in schizophrenia? A focus on progesterone-dopamine interactions","volume":"74","author":"Sun","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0069","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbalip.2008.09.007","article-title":"Lysophosphatidylcholine-induced apoptosis in H19-7 hippocampal progenitor cells is enhanced by the upregulation of Fas Ligand","volume":"1791","author":"Sun","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.psychres.2022.114762_bib0070","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41386-018-0278-3","article-title":"Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia","volume":"44","author":"Takeuchi","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.psychres.2022.114762_bib0071","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1038\/tp.2016.142","article-title":"Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations","volume":"6","author":"Tessier","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114762_bib0072","unstructured":"The World Medical Association (Internet), 2013. Declaration of Helsinki ethical principles of medical research involving human subjects. http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/."},{"issue":"3","key":"10.1016\/j.psychres.2022.114762_bib0073","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41386-020-00872-9","article-title":"Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia","volume":"46","author":"Valle-Le\u00f3n","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.psychres.2022.114762_bib0074","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0278-5846(97)00034-1","article-title":"A longitudinal study of cerebrospinal fluid angiotensin-converting enzyme in neuroleptic-treated schizophrenia","volume":"21","author":"Wahlbeck","year":"1997","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2022.114762_bib0075","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/glia.23986","article-title":"Quetiapine promotes oligodendroglial process outgrowth and membrane expansion by orchestrating the effects of Olig1","volume":"69","author":"Wang","year":"2021","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0076","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.schbul.a033315","article-title":"Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort","volume":"24","author":"Wiersma","year":"1998","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.psychres.2022.114762_bib0077","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090426","article-title":"Microglia activated by excess cortisol induce HMGB1 acetylation and neuroinflammation in the hippocampal DG region of mice following cold exposure","volume":"9","author":"Xu","year":"2019","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.psychres.2022.114762_bib0078","doi-asserted-by":"crossref","first-page":"e42165","DOI":"10.1371\/journal.pone.0042165","article-title":"Associations between purine metabolites and clinical symptoms in schizophrenia","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.psychres.2022.114762_bib0079","doi-asserted-by":"crossref","first-page":"e9508","DOI":"10.1371\/journal.pone.0009508","article-title":"Homeostatic imbalance of purine catabolism in first-episode neuroleptic-na\u00efve patients with schizophrenia","volume":"5","author":"Yao","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.psychres.2022.114762_bib0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0920-9964(99)00095-X","article-title":"Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients","volume":"42","author":"Yao","year":"2000","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.psychres.2022.114762_bib0081","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/pcn.12024","article-title":"S100B and schizophrenia","volume":"67","author":"Yelmo-Cruz","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2022.114762_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2019.100788","article-title":"Neurosteroids as regulators of neuroinflammation","volume":"55","author":"Yilmaz","year":"2019","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.psychres.2022.114762_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155441","article-title":"Serum interleukin-6 in schizophrenia: a system review and meta-analysis","volume":"141","author":"Zhou","year":"2021","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.psychres.2022.114762_bib0084","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.euroneuro.2017.06.011","article-title":"How well do patients with a first episode of schizophrenia respond to antipsychotics: a systematic review and meta-analysis","volume":"27","author":"Zhu","year":"2017","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122003560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122003560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:56:13Z","timestamp":1759038973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178122003560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":84,"alternative-id":["S0165178122003560"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114762","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114762"}}